(Q40774494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8226563%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

review article

1 reference

title

Management of immunocompromised patients with evidence of an invasive mycosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8226563%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

Walsh TJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8226563%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

publication date

1 October 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8226563%20AND%20SRC:MED&resulttype=core&format=json

Hematology / Oncology Clinics of North America

27 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8226563%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8226563%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8226563%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

1003-1026

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8226563%20AND%20SRC:MED&resulttype=core&format=json

New spectrum of fungal infections in patients with cancer

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Fusarium. A newly recognized fungal pathogen in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

The Emerging Role of Fusarium Infections in Patients with Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

High-resolution ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific chest roentgenograms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Clinical evaluation of the lysis-centrifugation blood culture system for the detection of fungemia and comparison with a conventional biphasic broth blood culture system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Chronic systemic candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Prospective study of Candida endophthalmitis in hospitalized patients with candidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Favorable outcome of invasive aspergillosis in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Mucormycosis: association with deferoxamine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Treatment of invasive aspergillosis with itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Candida infection of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Fluconazole failure in the treatment of invasive mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Late recurrent Candida endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Comparative Safety, Tolerance, and Pharmacokinetics of Amphotericin B Lipid Complex and Amphotericin B Desoxycholate in Healthy Male Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Hepatosplenic candidiasis: successful treatment with fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Safety and pharmacokinetics of fluconazole in children with neoplastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Extrapulmonary cryptococcosis in immunocompromised infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Pulmonary disease caused by Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Open lung biopsy in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Esophageal infections in immunosuppressed patients after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Diagnosis and successful treatment of fusariosis in the compromised host

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Phycomycosis complicating leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Aspergillosis complicating neoplastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Factors associated with fatal hemoptysis in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

The child with cancer and infection. II. Nonbacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Urinary tract candidiasis: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Azole antifungal agents: emphasis on new triazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

The value of fungal surveillance cultures as predictors of systemic fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Pathogenesis and treatment of recurrent vulvovaginal candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Hepatic candidiasis in cancer patients: the evolving picture of the syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Hepatosplenic candidiasis, a late manifestation of Candida septicaemia in neutropenic patients with haematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Aspergillus pericarditis: clinical and pathologic features in the immunocompromised patient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Candida epiglottitis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Treatment of systemic fungal infections: recent progress and current problems

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Bacterial esophagitis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Candidal suppurative peripheral thrombophlebitis: recognition, prevention, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Disseminated Histoplasmosis Complicating Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Esophageal candidiasis. Managing an increasingly prevalent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Fungal infections of the central nervous system: comparative analysis of risk factors and clinical signs in 57 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Empiric Therapy with Amphotericin B in Febrile Granulocytopenic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Trichosporon beigelii, an emerging pathogen resistant to amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Colony-stimulating factors and host defense

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Risk factors for hospital-acquired candidemia. A matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Candida tropicalis: A Major Pathogen in Immunocompromised Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Prophylaxis of oropharyngeal candidiasis with clotrimazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930215-6

7 January 2021

10.1016/S0889-8588(18)30215-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8226563%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference